Pumpers and bashersEveryone just stop making noise!
Pumpers, you are pumping the wrong thing. You keep talking about the results in July. Those will simply show that the drug is not poison. The phase 1 trial was not why we had a huge run up... it was the payout from the licensee. What will really drive this stock will be the annoucement that we received a first payment from the licensee.
Bashers, you will get your short play. Biotech companies are the easiest to short.
We all win... longs will win and shorts will win. Just don't be the fool who changes plans mid way.